A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)

Clinical Trial ID NCT02092922

PubWeight™ 3.20^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02092922

Top papers